Serial 79255825

What this means for you

Registered since 17 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79255825

Registration number

6010188

Mark type

Design / logo

Filed

16 Nov 2018

Published for opposition

31 Dec 2019

Registered

17 Mar 2020

Attorney of record

Douglas R. Wolf

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products, namely, pharmaceutical preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; diagnostic medical products for medical use, namely, medical diagnostic reagents, diagnostic agents, preparations and substances for medical purposes; pharmaceutical healthcare preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; medicinal preparations and substances, namely, medical diagnostic reagents, diagnostic agents, preparations and substances for medical purposes and pharmaceutical preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biochemical preparations for medical or veterinary used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; chemical reagents for medical or veterinary use; biological reagents for medical or veterinary use, namely, biological preparations used to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biological preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; chemical preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biotechnological preparations in the nature of pharmaceutical preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; biotechnological products in the nature of pharmaceutical preparations for medical use to treat autism spectrum disorder and neurological, psychiatric, oncological, and immune system related diseases or disorders; diagnostic preparations for medical use; diagnostic or monitoring biomarker reagents for medical purposes used to treat autism spectrum disorder
• Class 009 — Scientific and electric apparatus: Data processing equipment, computing apparatus in the nature of computer hardware; downloadable computer spreadsheet and word processing software for general use; computer systems comprising computer hardware and recorded computer programs for capturing, collecting, converting, analyzing, communicating, processing, receiving, recording, storing and transmitting data, images and information
• Class 035 — Advertising and business services: Business consulting; project management services for others for business purposes; compilation and management of databases and central data files in the field of medicine; creation of central data files in the nature of compiling data in the field of medicine other than for research purposes; compilation of statistics; collection and systemization of data in a central file; business information, namely, provision of commercial information in the field of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials; data processing services; business data analysis services; statistical and commercial analysis services for biomedical institutions and for medical and medical research institutions for business purposes; statistical and commercial analysis of technical data via computers for business purposes; computerized data processing; statistical and commercial data analysis services in the fields of public health, health care, bio-medicine as well as clinical trials for business purposes; compilation of information into computer databases for research and analysis in the fields of biomedicine and clinical trials
• Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design services relating to the development of therapeutic products; therapeutic product development featuring industrial analysis and research services; design and development of computer hardware and software; engineering services featuring technical data analysis services; pharmaceutical and biomedical research services; provision of online, non-downloadable software via a website for analysis in the fields of biomedical research, clinical trial data and clinical trials; provision of a non-downloadable web-based software used to access information in the fields of biomedical research and clinical trials as well as related data; provision of online, non-downloadable software via a database used to access biomedical research and clinical trial data; biomedical research services; provision of scientific research information in the fields of biomedicine and clinical trials; Therapeutic product design development featuring scientific data analysis services; design and development of software; medical research services; database design in the field of medicine
• Class 044 — Medical, beauty and agricultural services: Medical services, namely, medical analysis services; provision of information in the fields of medicine, health and health care

Owner

• Stalicla SA, CH
• Stalicla SA, CH
• Stalicla SA, CH

Prosecution history

• 16 Mar 2026 — TEAS SECTION 71 & 15 RECEIVED
• 17 Mar 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
• 25 Aug 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
• 01 Aug 2020 — FINAL DISPOSITION NOTICE SENT TO IB
• 01 Aug 2020 — FINAL DISPOSITION PROCESSED
• 17 Jun 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 17 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
• 04 Jan 2020 — NOTIFICATION PROCESSED BY IB
• 31 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 31 Dec 2019 — PUBLISHED FOR OPPOSITION
• 18 Dec 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 18 Dec 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
• 11 Dec 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 26 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 26 Nov 2019 — EXAMINER'S AMENDMENT ENTERED